4//SEC Filing
CDK ASSOCIATES, L.L.C. 4
Accession 0000919574-18-008210
CIK 0001183765other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:30 PM ET
Size
10.5 KB
Accession
0000919574-18-008210
Insider Transaction Report
Form 4
CDK ASSOCIATES, L.L.C.
Director
Transactions
- Purchase
Common Stock
2018-12-26$3.45/sh+25,000$86,250→ 1,584,241 total
CAXTON CORP
Director
Transactions
- Purchase
Common Stock
2018-12-26$3.45/sh+25,000$86,250→ 1,584,241 total
Morenstein Scott D
Director
Transactions
- Purchase
Common Stock
2018-12-26$3.45/sh+25,000$86,250→ 1,584,241 total
Kovner Bruce
Director
Transactions
- Purchase
Common Stock
2018-12-26$3.45/sh+25,000$86,250→ 1,584,241 total
Footnotes (1)
- [F1]These shares are held by CDK Associates, L.L.C. and may be deemed to be beneficially owned by (i) Scott Morenstein, a Managing Director of Caxton Alternative Management LP, the investment manager of CDK Associates, L.L.C., (ii) Caxton Corporation, the manager of CDK Associates, LLC and (iii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Molecular Templates, Inc.
CIK 0001183765
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001576081
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 5:30 PM ET
- Size
- 10.5 KB